D
Tarsus Pharmaceuticals, Inc. TARS
$58.85 $2.243.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 38.90% 29.70% 44.84% 40.18% -5.94%
Total Depreciation and Amortization 89.54% 70.37% 24.50% 16.39% 31.32%
Total Amortization of Deferred Charges 44.55% 21.93% 24.32% 27.72% 9.78%
Total Other Non-Cash Items -19.11% -5.97% 23.84% 28.02% 97.05%
Change in Net Operating Assets -259.53% 77.76% -104.03% 462.85% 229.12%
Cash from Operations -104.02% 45.35% 43.61% 73.26% 39.55%
Capital Expenditure 3.66% -239.08% -- 24.80% -32.02%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -28.41% 66.34% -433.34% -92.86% -160.86%
Cash from Investing -27.59% 65.82% -433.75% -93.40% -163.23%
Total Debt Issued -- -- -- -100.00% --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -27.16% 37.38% -85.19% -99.32% 425.49%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -95.39% 25.55% -85.19% -99.39% 8,197.84%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -527.59% 359.17% -4,469.80% -104.07% -130.93%